Pillstats
Rx only · Capsule · Oral

Calcitriol

Calcitriol

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1894
US makers9 labelers
Packages22
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.055$0.111$0.166$0.221Dec 2025Apr 2026Jul 2026
$0.185
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
9
Active US suppliers
41%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9.5K19K28K38K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
1.4M
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 15, 2018
    RECALLRecall (Class III): Calcitriol Oral Solution, 1 mcg/mL, 15 mL bottle, Rx Only, Distributed by: Ranbaxy Pharmaceuticals Inc. Jacksonville, F…

    Subpotency: lower than expected potency result was obtained at the 18 month stability time point. — Recalling firm: Validus Pharmaceuticals, Inc. — U.S. nationwide